Illinois is set to receive at least $23 million from opioid settlements with eight pharmaceutical companies, as Attorney General Kwame Raoul announced in the latest effort to confront a crisis that has devastated scores of families. According to the Chicago Sun-Times, the companies engaged in deceptive practices to push prescriptions of opioids, contributing to an epidemic of addiction.
As part of a broader $720 million total settlement for nine states, these funds aim to address the impacts of a crisis that continues to affect families across the socioeconomic spectrum. "As long as Illinois families continue to experience the devastating impacts of opioid addiction, my office will continue to work with other attorneys general to hold companies responsible for fueling the opioid crisis," Raoul said, as reported by WTVO.
The settlements include contributions from several companies, including Mylan, Hikma, Amneal, and others, with payment schedules ranging from one to ten years. Notably, Illinois has already collected about $1.4 billion as part of nationwide settlements with pharmaceutical entities, according to the Illinois Attorney General's office.
Further stipulations of the agreement include a prohibition on the implicated companies from ever promoting opioid products or making or selling pills containing over 40 milligrams of oxycodone. Additionally, they are required to more closely monitor and reportedly report suspicious orders. WTVO also noted that states could alternatively receive cash settlements instead of free pharmaceutical products from the manufacturers.
These financial remedies come against a sober backdrop, underscored by statistics from the U.S. Centers for Disease Control and Prevention, which estimate roughly 725,000 Americans lost their lives to opioid-related overdoses between 1999 and 2022. The financial settlements represent a continued commitment to hold pharmaceutical companies accountable and to mitigate the long-term effects of the opioid crisis on communities across the country.
